semaglutide oral fda Approves High-Dose 25mg FDA Approves First Oral GLP-1

Retrieved from SingleCare-h

Meanwhile, the SURMOUNT-1 trial demonstrated that patients taking tirzepatide achieved average weight loss of up to 22.5% , making it one of the most effective prescription weight loss medications studied to date

The same medication, semaglutide, is sold under a different brand name, Wegovy, for weight loss

Key takeaways GLP-1 medications do not inherently cause muscle wasting. Most weight lost on semaglutide or tirzepatide is fat , not muscle. Some lean-mass loss during weight loss reflects adaptive remodeling , not pathology. Adequate protein intake and resistance training significantly reduce muscle loss during GLP-1 therapy. Do GLP-1 Medications Cause Muscle Wasting

The medication may still be fine, or it may have degraded past the point of effectiveness